ORIGINAL RESEARCH
Published on 19 Jul 2023
Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCORE
doi 10.3389/fphar.2023.1206893
- 1,098 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Chronic Myeloid Leukemia: From Targeted Therapy to Treatment-Free Remission
Chronic Myeloid Leukemia: From Targeted Therapy to Treatment-Free Remission
4,195
Total downloads
16k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 04 Jul 2023
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients
doi 10.3389/fphar.2023.1212392
- 3,338 views
ORIGINAL RESEARCH
Published on 31 May 2023
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
doi 10.3389/fphar.2023.1187066
- 2,232 views
- 4 citations
ORIGINAL RESEARCH
Published on 26 May 2023
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26+ leukemia stem cells
doi 10.3389/fphar.2023.1194712
- 1,989 views
- 5 citations
BRIEF RESEARCH REPORT
Published on 23 Mar 2023
Treatment discontinuation following low-dose TKIs in 248 chronic myeloid leukemia patients: Updated results from a campus CML real-life study
doi 10.3389/fphar.2023.1154377
- 1,738 views
- 12 citations
ORIGINAL RESEARCH
Published on 16 Mar 2023
Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience
doi 10.3389/fonc.2023.1138683
- 1,390 views
ORIGINAL RESEARCH
Published on 23 Jan 2023
Successful treatment discontinuation in CML patients with full-dose and low-dose TKI: Results from real-world practice
doi 10.3389/fphar.2023.1101743
- 1,734 views
- 4 citations
ORIGINAL RESEARCH
Published on 06 Dec 2022
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation
doi 10.3389/fonc.2022.1028871
- 1,347 views
- 5 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted:
Impact
- 16kTopic views
- 11kArticle views
- 4,195Article downloads